U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2022
324
Substance Class Protein
Created
by admin
on Tue Apr 01 21:09:28 GMT 2025
Edited
by admin
on Tue Apr 01 21:09:28 GMT 2025
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IMMUNOMODULATOR
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
LDJ89SS0YG
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
BTCT-4465A
Preferred Name English
MOSUNETUZUMAB
INN   USAN  
Official Name English
RG-7828
Code English
MOSUNETUZUMAB [USAN]
Common Name English
Mosunetuzumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (CD3E ANTIGEN)) AND IMMUNOGLOBULIN G1-KAPPA ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20) HETERODIMERHUMANIZED MONOCLONAL ANTIBODY BISPECIFIC.GAMMA.1 HEAVY CHAIN ANT
Systematic Name English
RO7030816
Code English
RO-7030816
Code English
IMMUNOGLOBULIN G1, HUMANIZED BISPECIFIC, ANTI-(HUMAN CD3 (ANTIGEN))(BTCT4465A .GAMMA.1-CHAIN), DISULFIDE WITH ANTI-(HUMAN CD3 (ANTIGEN)) BTCT4465A .KAPPA.4-CHAIN, ANTI-(HUMAN CD20 (ANTIGEN)) BTCT4465A .GAMMA.3-CHAIN AND ANTI-(HUMAN CD20 (ANTIGEN)) BTCT44
Systematic Name English
BTCT4465A
Code English
RG7828
Code English
mosunetuzumab [INN]
Common Name English
RG-7828 (ANTI-CD20 & CD3)
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 663418
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
Code System Code Type Description
FDA UNII
LDJ89SS0YG
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
INN
10621
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
CAS
1905409-39-3
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
USAN
FG-70
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
DAILYMED
LDJ89SS0YG
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
SMS_ID
100000177733
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
NCI_THESAURUS
C129691
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
DRUG BANK
DB15434
Created by admin on Tue Apr 01 21:09:28 GMT 2025 , Edited by admin on Tue Apr 01 21:09:28 GMT 2025
PRIMARY
From To
1_22 1_96
1_149 1_205
1_266 1_326
1_372 1_430
2_22 2_96
2_146 2_202
2_263 2_323
2_369 2_427
1_225 4_213
1_231 2_228
1_234 2_231
2_222 3_219
3_23 3_94
3_139 3_199
4_23 4_87
4_133 4_193
Related Record Type Details
B-LYMPHOCYTE ANTIGEN CD20
TARGET->ANTIGEN
Mosunetuzumab-AXGB
SUB_CONCEPT->SUBSTANCE
CD3
CD3
TARGET -> ACTIVATOR
Related Record Type Details
MOSUNETUZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966